(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Esports Entertainment Group, Health Sciences Acquisitions Corporation 2, and Fusion Pharmaceuticals.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Esports Entertainment Group (GMBLW) | 0.10 | 38.57% | 2023-02-15 01:13:08 |
| 2 | Health Sciences Acquisitions Corporation 2 (HSAQ) | 13.31 | 24.16% | 2023-02-15 07:48:16 |
| 3 | Fusion Pharmaceuticals (FUSN) | 4.42 | 21.76% | 2023-02-14 21:23:16 |
| 4 | Marathon (MARA) | 7.95 | 18.32% | 2023-02-15 15:46:15 |
| 5 | Inpixon (INPX) | 1.26 | 17.75% | 2023-02-15 15:48:16 |
| 6 | Coinbase (COIN) | 68.99 | 16.87% | 2023-02-15 15:53:47 |
| 7 | QuantumScape (QS) | 10.45 | 16.76% | 2023-02-15 15:53:21 |
| 8 | AMC (AMC) | 5.22 | 16% | 2023-02-15 15:38:54 |
| 9 | Industrial Logistics Properties Trust (ILPT) | 4.72 | 15.12% | 2023-02-15 13:41:18 |
| 10 | Riot Blockchain (RIOT) | 6.66 | 12.97% | 2023-02-15 15:51:58 |
The three biggest losers today are Greenrose Acquisition Corp., Sabre Corporation, and Harpoon Therapeutics.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Greenrose Acquisition Corp. (GNRS) | 0.50 | -27.54% | 2023-02-15 01:42:17 |
| 2 | Sabre Corporation (SABR) | 5.61 | -18.51% | 2023-02-15 15:47:50 |
| 3 | Harpoon Therapeutics (HARP) | 0.98 | -15.52% | 2023-02-15 05:10:14 |
| 4 | Sorrento Therapeutics (SRNE) | 0.17 | -11.85% | 2023-02-15 15:18:30 |
| 5 | Akamai Technologies (AKAM) | 78.49 | -10.59% | 2023-02-15 15:56:26 |
| 6 | Devon Energy (DVN) | 57.19 | -10.55% | 2023-02-15 15:57:53 |
| 7 | Hecla Mining (HL) | 5.11 | -9.47% | 2023-02-15 15:59:42 |
| 8 | Happiness Biotech Group Limited (HAPP) | 4.50 | -8.9% | 2023-02-15 05:09:45 |
| 9 | Ideanomics (IDEX) | 0.15 | -7.43% | 2023-02-15 11:47:18 |
| 10 | GreenPower Motor Company (GP) | 2.91 | -7.32% | 2023-02-15 03:10:15 |
Winners today
1. Esports Entertainment Group (GMBLW) – 38.57%
NASDAQ ended the session with Esports Entertainment Group jumping 38.57% to $0.10 on Wednesday, after five successive sessions in a row of losses. NASDAQ rose 0.92% to $12,070.59, after two sequential sessions in a row of gains, on what was a somewhat positive trend trading session today.
Yearly Top and Bottom Value
Esports Entertainment Group’s stock is valued at $0.10 at 16:32 EST, higher than its 52-week high of $0.10.
More news about Esports Entertainment Group.
2. Health Sciences Acquisitions Corporation 2 (HSAQ) – 24.16%
Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
NASDAQ ended the session with Health Sciences Acquisitions Corporation 2 rising 24.16% to $13.31 on Wednesday while NASDAQ rose 0.92% to $12,070.59.
Earnings Per Share
As for profitability, Health Sciences Acquisitions Corporation 2 has a trailing twelve months EPS of $-0.03.
Moving Average
Health Sciences Acquisitions Corporation 2’s worth is way above its 50-day moving average of $10.06 and way higher than its 200-day moving average of $9.96.
Volume
Today’s last reported volume for Health Sciences Acquisitions Corporation 2 is 119605 which is 60.03% above its average volume of 74737.
Yearly Top and Bottom Value
Health Sciences Acquisitions Corporation 2’s stock is valued at $13.31 at 16:32 EST, below its 52-week high of $13.80 and way above its 52-week low of $9.41.
More news about Health Sciences Acquisitions Corporation 2.
3. Fusion Pharmaceuticals (FUSN) – 21.76%
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the alpha particle payloads to tumors. Its lead product candidate is FPI-1434 that is in Phase 1 clinical trials as a monotherapy in patients with solid tumors expressing insulin-like growth factor 1 receptor. The company is also conducting additional preclinical studies of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors to further assess the anti-tumor activity, and dosing schedule and pharmacodynamics of the combinations. In addition, it is involved in the progressing of its earlier-stage product candidate, FPI-1966 into clinical development for the treatment of head and neck, and bladder cancers expressing fibroblast growth factor receptor. Fusion Pharmaceuticals Inc. was incorporated in 2014 and is headquartered in Hamilton, Canada.
NASDAQ ended the session with Fusion Pharmaceuticals rising 21.76% to $4.42 on Wednesday while NASDAQ rose 0.92% to $12,070.59.
Earnings Per Share
As for profitability, Fusion Pharmaceuticals has a trailing twelve months EPS of $-1.825.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -32.71%.
More news about Fusion Pharmaceuticals.
4. Marathon (MARA) – 18.32%
Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines cryptocurrencies with a focus on the blockchain ecosystem and the generation of digital assets in United States. As of December 31, 2021, it had approximately 8,115 bitcoins, which included the 4,794 bitcoins held in the investment fund. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.
NASDAQ ended the session with Marathon jumping 18.32% to $7.95 on Wednesday while NASDAQ jumped 0.92% to $12,070.59.
Earnings Per Share
As for profitability, Marathon has a trailing twelve months EPS of $-0.13.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -34.72%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Marathon’s stock is considered to be oversold (<=20).
More news about Marathon.
5. Inpixon (INPX) – 17.75%
Inpixon, together with its subsidiaries, provides big data analytics and location based products and related services worldwide. It offers Inpixon Sensor 4000, a passive RF sensor to detect signals ranging from pings to a cell tower to active wireless transmissions; Inpixon IPA Pod offers entry-level barriers to radio detection based indoor positioning; Inpixon Smart School Safety Network solution, a combination of wristbands, ID badges, gateways, and proprietary backend software for school; UWB Sensor Module helps in detection with location; Inpixon GPS 900, a personnel, vehicle, and asset tracking solution; IPA Security, a mobile security and detection product that locates devices operating within a monitored area; Inpixon MDM Connector enables two-way communication between our IPA Security platform and a third-party mobile device management system; Inpixon On-Premises Analytics security customers running systems; and Inpixon GPS Viewer, a browser-based portal used to monitor location and movements of GPS-enabled tracking devices. The company also offers data analytics solutions, such as IPA Wi-Fi, a cloud-based data analytics engine that provides visitor metrics and insights by ingesting diverse data from IoT, third-party, and proprietary sensors; IPA Video analytics to help security personnel combat crime and secure indoor locations; Inpixon Captive Portal, a splash page for their customers to accept terms and conditions before using Wi-Fi; and Shoom Products cloud based applications and analytics for the media and publishing industry. It serves shopping malls, corporate offices, healthcare facilities, government agencies, local publications, and others. The company was formerly known as Sysorex Global and changed its name to Inpixon in March 2017. Inpixon is headquartered in Palo Alto, California.
NASDAQ ended the session with Inpixon jumping 17.75% to $1.26 on Wednesday while NASDAQ jumped 0.92% to $12,070.59.
Earnings Per Share
As for profitability, Inpixon has a trailing twelve months EPS of $-1.015.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -70.04%.
Sales Growth
Inpixon ‘s sales growth is 6.1% for the present quarter and negative 69.1% for the next.
Volume
Today’s last reported volume for Inpixon is 4403520 which is 108.82% above its average volume of 2108700.
Moving Average
Inpixon ‘s worth is way under its 50-day moving average of $1.60 and way under its 200-day moving average of $7.67.
Yearly Top and Bottom Value
Inpixon ‘s stock is valued at $1.26 at 16:32 EST, way below its 52-week high of $31.35 and way above its 52-week low of $0.87.
More news about Inpixon .
6. Coinbase (COIN) – 16.87%
Coinbase Global, Inc. provides financial infrastructure and technology for the cryptoeconomy in the United States and internationally. The company offers the primary financial account in the cryptoeconomy for retailers; a marketplace with a pool of liquidity for transacting in crypto assets for institutions; and technology and services that enable ecosystem partners to build crypto-based applications and securely accept crypto assets as payment. Coinbase Global, Inc. was founded in 2012 and is based in Wilmington, Delaware.
NASDAQ ended the session with Coinbase rising 16.87% to $68.99 on Wednesday while NASDAQ rose 0.92% to $12,070.59.
Earnings Per Share
As for profitability, Coinbase has a trailing twelve months EPS of $13.29.
PE Ratio
Coinbase has a trailing twelve months price to earnings ratio of 5.19. Meaning, the purchaser of the share is investing $5.19 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 91.66%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 327.1%, now sitting on 7.84B for the twelve trailing months.
Volatility
Coinbase’s last week, last month’s, and last quarter’s current intraday variation average was a negative 6.96%, a positive 0.79%, and a positive 6.00%.
Coinbase’s highest amplitude of average volatility was 6.96% (last week), 7.22% (last month), and 6.00% (last quarter).
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 97.7% and a negative 101.2%, respectively.
Volume
Today’s last reported volume for Coinbase is 23719700 which is 48.68% above its average volume of 15953300.
More news about Coinbase.
7. QuantumScape (QS) – 16.76%
QuantumScape Corporation, a development stage company, focuses on the development and commercialization of solid-state lithium-metal batteries for electric vehicles and other applications. The company was founded in 2010 and is headquartered in San Jose, California.
NYSE ended the session with QuantumScape jumping 16.76% to $10.45 on Wednesday, after four consecutive sessions in a row of gains. NYSE fell 0.19% to $15,994.78, following the last session’s downward trend on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, QuantumScape has a trailing twelve months EPS of $-3.85.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.32%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 41.7% and a negative 46.2%, respectively.
More news about QuantumScape.
8. AMC (AMC) – 16%
AMC Entertainment Holdings, Inc., through its subsidiaries, engages in the theatrical exhibition business. The company owns, operates, or has interests in theatres in the United States and Europe. As of March 1, 2022, it operated approximately 950 theatres and 10,600 screens. The company was founded in 1920 and is headquartered in Leawood, Kansas.
NYSE ended the session with AMC jumping 16% to $5.22 on Wednesday, after five consecutive sessions in a row of losses. NYSE slid 0.19% to $15,994.78, following the last session’s downward trend on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, AMC has a trailing twelve months EPS of $-39.15.
Moving Average
AMC’s value is below its 50-day moving average of $5.77 and way below its 200-day moving average of $10.59.
More news about AMC.
9. Industrial Logistics Properties Trust (ILPT) – 15.12%
ILPT is a real estate investment trust, or REIT, that owns and leases industrial and logistics properties throughout the United States. ILPT is managed by the operating subsidiary of The RMR Group Inc. (Nasdaq: RMR), an alternative asset management company that is headquartered in Newton, MA.
NASDAQ ended the session with Industrial Logistics Properties Trust jumping 15.12% to $4.72 on Wednesday, following the last session’s downward trend. NASDAQ rose 0.92% to $12,070.59, after two consecutive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, Industrial Logistics Properties Trust has a trailing twelve months EPS of $1.36.
PE Ratio
Industrial Logistics Properties Trust has a trailing twelve months price to earnings ratio of 3.47. Meaning, the purchaser of the share is investing $3.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.43%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 87.7%, now sitting on 338.31M for the twelve trailing months.
Sales Growth
Industrial Logistics Properties Trust’s sales growth is 88.3% for the ongoing quarter and 49.8% for the next.
Moving Average
Industrial Logistics Properties Trust’s value is way higher than its 50-day moving average of $3.90 and way below its 200-day moving average of $7.96.
More news about Industrial Logistics Properties Trust.
10. Riot Blockchain (RIOT) – 12.97%
Riot Blockchain, Inc., together with its subsidiaries, focuses on bitcoin mining operations in North America. It operates through Bitcoin Mining, Data Center Hosting, and Electrical Products and Engineering segments. As of December 31, 2021, it operated approximately 30,907 miners. Riot Blockchain, Inc. was incorporated in 2000 and is headquartered in Castle Rock, Colorado.
NASDAQ ended the session with Riot Blockchain rising 12.97% to $6.66 on Wednesday while NASDAQ rose 0.92% to $12,070.59.
Earnings Per Share
As for profitability, Riot Blockchain has a trailing twelve months EPS of $-0.3.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -36.5%.
Moving Average
Riot Blockchain’s worth is way above its 50-day moving average of $4.85 and above its 200-day moving average of $6.40.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 87.5% and 95.2%, respectively.
More news about Riot Blockchain.
Losers Today
1. Greenrose Acquisition Corp. (GNRS) – -27.54%
Greenrose Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2019 and is based in Amityville, New York.
NASDAQ ended the session with Greenrose Acquisition Corp. sliding 27.54% to $0.50 on Wednesday while NASDAQ rose 0.92% to $12,070.59.
Earnings Per Share
As for profitability, Greenrose Acquisition Corp. has a trailing twelve months EPS of $-0.26.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 189.14%.
More news about Greenrose Acquisition Corp..
2. Sabre Corporation (SABR) – -18.51%
Sabre Corporation, through its subsidiary, Sabre Holdings Corporation, provides software and technology solutions for the travel industry worldwide. It operates in two segments, Travel Solutions and Hospitality Solutions. The Travel Solutions segment operates as a business-to-business travel marketplace that offers travel content, such as inventory, prices, and availability from a range of travel suppliers, including airlines, hotels, car rental brands, rail carriers, cruise lines, and tour operators with a network of travel buyers comprising online and offline travel agencies, travel management companies, and corporate travel departments. This segment also provides a portfolio of software technology products and solutions through software-as-a-service (SaaS) and hosted delivery models to airlines and other travel suppliers. Its products include reservation systems for carriers, commercial and operations products, agency solutions, and data-driven intelligence solutions. The Hospitality Solutions segment provides software and solutions to hoteliers through SaaS and hosted delivery models. Sabre Corporation was incorporated in 2006 and is headquartered in Southlake, Texas.
NASDAQ ended the session with Sabre Corporation dropping 18.51% to $5.61 on Wednesday, following the last session’s downward trend. NASDAQ rose 0.92% to $12,070.59, after two consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, Sabre Corporation has a trailing twelve months EPS of $-4.42.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 54% and 61.7%, respectively.
Yearly Top and Bottom Value
Sabre Corporation’s stock is valued at $5.61 at 16:32 EST, way below its 52-week high of $12.08 and way higher than its 52-week low of $4.46.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Sabre Corporation’s stock is considered to be overbought (>=80).
More news about Sabre Corporation.
3. Harpoon Therapeutics (HARP) – -15.52%
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company's lead tri-specific t-cell activating construct (TriTAC) product candidate is HPN424, which is in Phase I/IIa clinical trials for the treatment of metastatic castration-resistant prostate cancer. It is also developing HPN536, which is in Phase I/IIa clinical trials for the treatment of ovarian cancer and other mesothelin-expressing tumors; HPN217 that is in Phase I/II clinical trials for the treatment of multiple myeloma; and HPN328, a product candidate in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors. The company has a discovery collaboration and license agreement with AbbVie Biotechnology Ltd. to develop and commercialize products that incorporate our proprietary TriTAC platform technology together with soluble T cell receptors. Harpoon Therapeutics, Inc. was founded in 2015 and is headquartered in South San Francisco, California.
NASDAQ ended the session with Harpoon Therapeutics dropping 15.52% to $0.98 on Wednesday while NASDAQ rose 0.92% to $12,070.59.
Earnings Per Share
As for profitability, Harpoon Therapeutics has a trailing twelve months EPS of $-2.31.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -150.96%.
Volume
Today’s last reported volume for Harpoon Therapeutics is 665898 which is 71.38% below its average volume of 2326700.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 28.8% and 24.2%, respectively.
Yearly Top and Bottom Value
Harpoon Therapeutics’s stock is valued at $0.98 at 16:32 EST, way below its 52-week high of $5.88 and way above its 52-week low of $0.59.
Moving Average
Harpoon Therapeutics’s value is way higher than its 50-day moving average of $0.87 and way under its 200-day moving average of $1.48.
More news about Harpoon Therapeutics.
4. Sorrento Therapeutics (SRNE) – -11.85%
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugate, as well as bispecific antibody approach; and Sofusa, a drug delivery technology that deliver biologic directly into the lymphatic system. Its clinical programs in development include anti-CD38 CAR-T therapy for the treatment of multiple myeloma, as well as for amyloidosis and graft versus host disease. The company develops resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for late stage cancer and osteoarthritis knee pain treatment; and ZTlido, a lidocaine delivery system for the treatment of postherpetic neuralgia. It engages in the development of SEMDEXA, an injectable viscous gel formulation, which is Phase III trial for the treatment of sciatica, a pathology of low back pain; SP-103, an investigational non-aqueous lidocaine topical system undergoing clinical development in chronic low back pain condition; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation for the treatment of fibromyalgia. It has collaboration with SmartPharm Therapeutics Inc. to develop gene-encoded antibody vaccine to protect against COVID-19; Celularity, Inc. for initiating Phase I/II clinical study, including up to 94 patients with COVID-19; Mount Sinai Health System to develop COVI-SHIELD, an antibody therapy targeting SARS-CoV-2 infection; and Mayo Clinic for Phase Ib pilot study using sofusa lymphatic drug delivery technology to deliver Ipilimumab in patient with melanoma. The company was founded in 2006 and is based in San Diego, California.
NASDAQ ended the session with Sorrento Therapeutics dropping 11.85% to $0.17 on Wednesday while NASDAQ rose 0.92% to $12,070.59.
Earnings Per Share
As for profitability, Sorrento Therapeutics has a trailing twelve months EPS of $-1.3.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -326.72%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 15.2%, now sitting on 54.98M for the twelve trailing months.
More news about Sorrento Therapeutics.
5. Akamai Technologies (AKAM) – -10.59%
Akamai Technologies, Inc. provides cloud services for securing, delivering, and optimizing content and business applications over the internet in the United States and internationally. The company offers cloud solutions to keep infrastructure, websites, applications, application programming interfaces, and users safe from various cyberattacks and online threats while enhancing performance. It also provides web and mobile performance solutions to enable dynamic websites and applications; media delivery solutions, including video streaming and video player services, game and software delivery, broadcast operations, authoritative domain name system, resolution, and data and analytics; and edge compute solutions to enable developers to deploy and distribute code at the edge. In addition, the company offers carrier offerings, including cybersecurity protection, parental controls, DNS infrastructure and content delivery solutions; and an array of service and support to assist customers with integrating, configuring, optimizing, and managing its offerings. It sells its solutions through direct sales and service organizations, as well as through various channel partners. Akamai Technologies, Inc. was incorporated in 1998 and is headquartered in Cambridge, Massachusetts.
NASDAQ ended the session with Akamai Technologies sliding 10.59% to $78.49 on Wednesday while NASDAQ jumped 0.92% to $12,070.59.
Earnings Per Share
As for profitability, Akamai Technologies has a trailing twelve months EPS of $3.37.
PE Ratio
Akamai Technologies has a trailing twelve months price to earnings ratio of 23.29. Meaning, the purchaser of the share is investing $23.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.51%.
Moving Average
Akamai Technologies’s value is way under its 50-day moving average of $87.59 and way below its 200-day moving average of $90.98.
Yearly Top and Bottom Value
Akamai Technologies’s stock is valued at $78.49 at 16:32 EST, way under its 52-week high of $123.25 and higher than its 52-week low of $76.28.
Volume
Today’s last reported volume for Akamai Technologies is 7027700 which is 444.43% above its average volume of 1290820.
More news about Akamai Technologies.
6. Devon Energy (DVN) – -10.55%
Devon Energy Corporation, an independent energy company, primarily engages in the exploration, development, and production of oil, natural gas, and natural gas liquids in the United States. It operates approximately 5,134 gross wells. Devon Energy Corporation was incorporated in 1971 and is headquartered in Oklahoma City, Oklahoma.
NYSE ended the session with Devon Energy dropping 10.55% to $57.19 on Wednesday while NYSE slid 0.19% to $15,994.78.
Earnings Per Share
As for profitability, Devon Energy has a trailing twelve months EPS of $-7.12.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 56.38%.
Sales Growth
Devon Energy’s sales growth is 41.7% for the ongoing quarter and 23.3% for the next.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Devon Energy’s stock is considered to be oversold (<=20).
Revenue Growth
Year-on-year quarterly revenue growth grew by 78.9%, now sitting on 17.48B for the twelve trailing months.
Yearly Top and Bottom Value
Devon Energy’s stock is valued at $57.19 at 16:32 EST, way below its 52-week high of $79.40 and way higher than its 52-week low of $48.86.
More news about Devon Energy.
7. Hecla Mining (HL) – -9.47%
Hecla Mining Company, together with its subsidiaries, discovers, acquires, develops, and produces precious and base metal properties in the United States and internationally. The company mines for silver, gold, lead, and zinc concentrates, as well as carbon material containing silver and gold for sale to custom smelters, metal traders, and third-party processors,; and doré containing silver and gold. It owns 100% interests in the Greens Creek mine located on Admiralty Island in southeast Alaska; the Lucky Friday mine situated in northern Idaho; the Casa Berardi mine located in the Abitibi region of northwestern Quebec, Canada; and the San Sebastian mine situated in the city of Durango, Mexico. The company also holds 100% interests in the Fire Creek mine located in Lander County, Nevada; and the Hollister and Midas mines situated in Elko County, Nevada. Hecla Mining Company was incorporated in 1891 and is headquartered in Coeur d'Alene, Idaho.
NYSE ended the session with Hecla Mining falling 9.47% to $5.11 on Wednesday, following the last session’s upward trend. NYSE slid 0.19% to $15,994.78, following the last session’s downward trend on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, Hecla Mining has a trailing twelve months EPS of $-0.03.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.09%.
Moving Average
Hecla Mining’s value is way under its 50-day moving average of $5.81 and above its 200-day moving average of $4.76.
Yearly Top and Bottom Value
Hecla Mining’s stock is valued at $5.11 at 16:32 EST, way below its 52-week high of $7.66 and way above its 52-week low of $3.41.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Hecla Mining’s stock is considered to be overbought (>=80).
More news about Hecla Mining.
8. Happiness Biotech Group Limited (HAPP) – -8.9%
Happiness Biotech Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company's product category includes lucidum spore powder, cordyceps mycelia, ejiao solution, American ginseng, and other products. It also offers a range of ganoderma lucidum products, such as essence oil, cleansing milk, shampoo, shower gel, and nourishing cream products under the Cai Zhi Ning brand, as well as edible fungi. In addition, the company provides disinfectants, non-medical face masks, and COVID-19 anti-body testing kits. It sells its products through distributors, large-scale chain drugstores, malls, and supermarkets under the Happiness brand. Happiness Biotech Group Limited was founded in 2004 and is headquartered in Nanping, the People's Republic of China.
NASDAQ ended the session with Happiness Biotech Group Limited sliding 8.9% to $4.50 on Wednesday, following the last session’s downward trend. NASDAQ rose 0.92% to $12,070.59, after two successive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, Happiness Biotech Group Limited has a trailing twelve months EPS of $-0.459.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -92.71%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 13%, now sitting on 95.59M for the twelve trailing months.
More news about Happiness Biotech Group Limited.
9. Ideanomics (IDEX) – -7.43%
Ideanomics, Inc. focuses on driving the adoption of commercial electric vehicles, associated energy consumption, and developing financial services and fintech products. Its Ideanomics Mobility division facilitates the adoption of electric vehicles by commercial fleet operators. This division also offers solutions for the procurement, financing, charging, and energy management needs for fleet operators of commercial electric vehicles. The company's Ideanomics Capital division provides fintech services, which focuses on the enhancement of efficiency, transparency, and profitability for the financial services industry. Ideanomics, Inc. was incorporated in 2004 and is headquartered in New York, New York.
NASDAQ ended the session with Ideanomics dropping 7.43% to $0.15 on Wednesday while NASDAQ rose 0.92% to $12,070.59.
Earnings Per Share
As for profitability, Ideanomics has a trailing twelve months EPS of $-0.461.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -71.64%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 54.5% and 60%, respectively.
Sales Growth
Ideanomics’s sales growth is 59.7% for the present quarter and 85.9% for the next.
Volume
Today’s last reported volume for Ideanomics is 11975500 which is 9.28% above its average volume of 10958500.
Yearly Top and Bottom Value
Ideanomics’s stock is valued at $0.15 at 16:32 EST, way below its 52-week high of $1.15 and above its 52-week low of $0.14.
More news about Ideanomics.
10. GreenPower Motor Company (GP) – -7.32%
GreenPower Motor Company Inc. develops, manufactures, and distributes electric vehicles for commercial markets in the United States and Canada. It offers all-electric transit, school, and charter buses. The company is based in Vancouver, Canada.
NASDAQ ended the session with GreenPower Motor Company dropping 7.32% to $2.91 on Wednesday, following the last session’s downward trend. NASDAQ jumped 0.92% to $12,070.59, after two sequential sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, GreenPower Motor Company has a trailing twelve months EPS of $-0.5.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -58.14%.
Moving Average
GreenPower Motor Company’s value is above its 50-day moving average of $2.70 and under its 200-day moving average of $3.11.
Yearly Top and Bottom Value
GreenPower Motor Company’s stock is valued at $2.91 at 16:32 EST, way below its 52-week high of $9.34 and way above its 52-week low of $1.67.
More news about GreenPower Motor Company.
Stay up to date with our winners and losers daily report
